Literature DB >> 17313080

[Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma].

Takayuki Suzuki1, Takashi Kumagai, Asako Kitano, Humito Kubo, Mikio Tabata, Yuji Kimura, Osamu Miura, Yasufumi Imai.   

Abstract

Malignant lymphoma is often accompanied by an autoimmune disorder. Here, we describe a 82-year-old woman with pure red cell aplasia (PRCA) complicated with relapsed diffuse large B-cell lymphoma. Primary treatment involving chemotherapy, continuous oral administration of prednisolone and a single infusion of rituximab was unsuccessful for both diseases, but the following treatments with 3 courses of rituximab alone for once a week dramatically improved the PRCA as well as the lymphoma. As PRCA complicated with lymphoma is rare, the ideal therapeutic strategy has not yet been established for it. Rituximab may be a good alternative for treating such cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313080

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  4 in total

1.  Waldenström's macroglobulinaemia complicated by pure red cell aplasia: a case report.

Authors:  Yuan-Yuan Li; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Blood Transfus       Date:  2013-05-27       Impact factor: 3.443

2.  Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.

Authors:  Efthimia Vlachaki; Konstantinos Tselios; Stella Charalambidou; Elizabeth Ioannidou; Ioannis Klonizakis
Journal:  Int J Hematol       Date:  2008-09-03       Impact factor: 2.490

3.  Anaemia in CD5 Negative Chronic Lymphoproliferative Disorder: Importance of Bone Marrow Examination.

Authors:  Mili Jain; Ayush Shukla; Ashutosh Kumar; Rashmi Kushwaha; Anil Kumar Tripathi
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 4.  Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.

Authors:  Efthymia Vlachaki; Michael D Diamantidis; Philippos Klonizakis; Styliani Haralambidou-Vranitsa; Elizabeth Ioannidou-Papagiannaki; Ioannis Klonizakis
Journal:  ScientificWorldJournal       Date:  2012-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.